Proof — Case Study

Cheers Health
Three weeks, not six months.

Science Intelligence™

A major retail door opened — but only for products whose every on-pack claim could clear the retailer's strict clinical evidence bar. No time for new trials. No appetite for a six-month review.

The Story

Cheers builds supplements for smarter drinking and liver health. A national retail distribution opportunity opened for a reformulated product system with a hard deadline attached. The retailer's science threshold: on-pack claims backed by qualifying double-blind, placebo-controlled RCTs at the formula's actual dose.

We ran an AI-powered Lit Review™ of the full formulation space — existing Cheers ingredients, new candidates, and branded forms — scored against the retailer's evidence standard. And we answered the bonus question: which recently published science could strengthen claims on the ingredients Cheers already sells today?

Cheers walked into the retail conversation with formulation options, claim-by-claim substantiation, and new literature supporting its existing lineup — in three weeks, not six months.

  • Lit Review™
  • Evidence scoring
  • Claims mapping
  • Retail-ready formulation builds
Results
36 ingredients
Evaluated and scored — 26 standard + 10 branded forms
36 qualifying studies
Design, blinding, N, dose, and outcomes captured for every study
13 high-priority ingredients
Tier A — strongest evidence, prioritized for the new formulation builds (plus 10 on-pack-eligible claims, 16 conditional, 8 off-pack)
4 formulation builds
Complete dosing, capsule payloads, claim counts, manufacturing flags
3 weeks
From kickoff to retail-ready substantiation

More work

Case StudyDesigns for HealthNot all vitamin D is equal.View →Case StudyEmerson Logistics1 order. 1 truck. 1 payment.View →Case StudyFlonaseOne dose. Six allergens.View →Case StudyHealthCareAislePrivate label, public proof.View →Case StudyiVIZIAWe see a better way.View →Case StudyLotriminAthlete's foot loves a comeback.View →Case StudyMetrum Research GroupComplexity, distilled.View →Case StudyNexium 24HRBold claims win.View →Case StudyQunol10x better absorption.View →Case StudyVera TherapeuticsClinical data, communicated.View →Case StudyBausch + Lomb83 studies. 35 new claims. Three weeks.View →Case StudyCheers Health — MOAScience, share-worthy.View →

Want results like these?

Every one of them started with the science.

Start a Project